Concise review: Optimizing expansion of bone marrow mesenchymal stem/stromal cells for clinical applications

Stem Cells Translational Medicine

Volumn 3, Issue 5, 2014, Pages 643-652

  Hoch, Allison I ^a   Kent Leach, J ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Bioreactor; Expansion; Growth factor; Hypoxia; Mesenchymal stromal stem cell; Progenitor

Indexed keywords

ALKALINE PHOSPHATASE; ASCORBIC ACID; BONE MORPHOGENETIC PROTEIN 2; CHITOSAN; COLLAGEN; DEXAMETHASONE; EPIDERMAL GROWTH FACTOR; FIBROBLAST GROWTH FACTOR 2; GELATIN; HYDROXYAPATITE; INTERLEUKIN 6; PLATELET DERIVED GROWTH FACTOR BB; POLYETHYLENE TEREPHTHALATE; SOMATOMEDIN C; TRANSFERRIN; TRANSFORMING GROWTH FACTOR BETA1; VASCULOTROPIN; WNT3A PROTEIN;

ARTICLE; BIOREACTOR; BONE DEVELOPMENT; BONE MARROW BIOPSY; BONE MINERALIZATION; CELL DENSITY; CELL DIFFERENTIATION; CELL HYPOXIA; CELL PROLIFERATION; CELL VIABILITY; CLINICAL TRIAL (TOPIC); COLONY FORMING UNIT; GRAFT VERSUS HOST REACTION; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; LASER DOPPLER FLOWMETRY; MESENCHYMAL STEM CELL TRANSPLANTATION; NONHUMAN; OSTEOGENESIS IMPERFECTA; OXYGEN TENSION; STROMA CELL;

BIOREACTOR; EXPANSION; GROWTH FACTOR; HYPOXIA; MESENCHYMAL STROMAL/STEM CELL; PROGENITOR;

BONE MARROW CELLS; CELL CULTURE TECHNIQUES; CELL SEPARATION; CELL- AND TISSUE-BASED THERAPY; HUMANS; MESENCHYMAL STEM CELL TRANSPLANTATION; MESENCHYMAL STROMAL CELLS;

EID: 84899683599     PISSN: 21576564     EISSN: 21576580     Source Type: Journal    
DOI: 10.5966/sctm.2013-0196     Document Type: Article

References (106)

1. Haynesworth SE, Goshima J, GoldbergVM et al. Characterization of cells with osteogenic potential from human marrow. Bone 1992;13: 81-88.
2. Pittenger MF, Mackay AM, Beck SC et al. Multilineage potential of adult human mesenchymal stem cells. Science 1999;284:143-147.
3. Hoch AI, Binder BY, Genetos DC et al. Differentiation-dependent secretion of proangiogenic factors by mesenchymal stem cells. PLoS One 2012;7:e35579.
4. Dominici M, Le Blanc K, Mueller I et al. Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy 2006;8:315-317.
5. Horwitz EM, Gordon PL, Koo WK et al. Isolated allogeneic bone marrow-derived mesenchymal cells engraft and stimulate growth in children with osteogenesis imperfecta: Implications for cell therapy of bone. Proc Natl Acad Sci USA 2002;99:8932-8937.
6. Le Blanc K, Rasmusson I, Sundberg B et al. Treatment of severe acute graft-versushost disease with third party haploidentical mesenchymal stemcells. Lancet2004;363:1439-1441.
7. Chen SL, FangWW, Ye F et al. Effect on left ventricular function of intracoronary transplantation of autologous bone marrow mesenchymal stem cell in patients with acute myocardial infarction. Am J Cardiol 2004;94:92-95.
8. Duijvestein M, Vos AC, Roelofs H et al. Autologous bone marrow-derived mesenchymal stromal cell treatment for refractory luminal Crohn's disease: Results of a phase I study. Gut 2010;59:1662-1669.
9. Mazzini L, Fagioli F, Boccaletti R et al. Stem cell therapy in amyotrophic lateral sclerosis: A methodological approach in humans. Amyotroph Lateral Scler Other Motor Neuron Disord 2003;4:158-161.
10. Field RE, Buchanan JA, Copplemans MG et al. Bone-marrow transplantation in Hurler's syndrome. Effect on skeletal development. J Bone Joint Surg Br 1994;76:975-981.
11. Galotto M, Berisso G, Delfino L et al. Stromal damage as consequence of high-dose chemo/radiotherapy in bone marrow transplant recipients. Exp Hematol 1999;27:1460-1466.
12. Friedenstein AJ, Gorskaja JF, Kulagina NN. Fibroblast precursors in normal and irradiated mouse hematopoietic organs. Exp Hematol 1976;4:267-274.
13. Banfi A, Muraglia A, Dozin B et al. Proliferation kinetics and differentiation potential of ex vivo expanded human bone marrow stromal cells: Implications for their use in cell therapy. Exp Hematol 2000;28:707-715.
14. Bertolo A, Mehr M, Janner-Jametti T et al. An in vitro expansion score for tissueengineering applications with human bone marrow-derived mesenchymal stem cells. J Tissue Eng Regen Med 2013 [Epub ahead of print].
15. Bonab MM, AlimoghaddamK, Talebian F et al. Aging of mesenchymal stem cell in vitro. BMC Cell Biol 2006;7:14.
16. Bruder SP, Jaiswal N, Haynesworth SE. Growth kinetics, self-renewal, and the osteogenic potential of purifiedhumanmesenchymal stem cells during extensive subcultivation and following cryopreservation. J Cell Biochem 1997;64:278-294.
17. Digirolamo CM, Stokes D, Colter D et al. Propagation and senescence of human marrow stromal cells in culture: A simple colonyforming assay identifies samples with the greatest potential to propagate and differentiate. Br J Haematol 1999;107:275-281.
18. Muraglia A, Cancedda R, Quarto R. Clonal mesenchymal progenitors from human bone marrowdifferentiate in vitro according toa hierarchical model. J Cell Sci 2000;113:1161-1166.
19. Bianchi G, Banfi A, Mastrogiacomo M et al. Ex vivo enrichment of mesenchymal cell progenitors by fibroblast growth factor 2. Exp Cell Res 2003;287:98-105.
20. Locklin RM, Oreffo RO, Triffitt JT. Effects of TGFbeta and bFGF on the differentiation of human bone marrow stromal fibroblasts. Cell Biol Int 1999;23:185-194.
21. Martin I, Muraglia A, Campanile G et al. Fibroblast growth factor-2 supports ex vivo expansion and maintenance of osteogenic precursors from human bone marrow. Endocrinology 1997;138:4456-4462.
22. Mastrogiacomo M, Cancedda R, Quarto R. Effect of different growth factors on the chondrogenic potential of human bone marrow stromal cells. Osteoarthritis Cartilage 2001;9 (suppl A):S36-S40.
23. Quito FL, Beh J, Bashayan O et al. Effects of fibroblast growth factor-4 (k-FGF) on longterm cultures of human bone marrow cells. Blood 1996;87:1282-1291.
24. Solchaga LA, Penick K, Porter JD et al. FGF-2 enhances the mitotic and chondrogenic potentials of human adult bone marrowderived mesenchymal stem cells. J Cell Physiol 2005;203:398-409.
25. Sotiropoulou PA, Perez SA, Salagianni M et al. Characterization of the optimal culture conditions for clinical scale production of human mesenchymal stem cells. STEM CELLS 2006;24:462-471.
26. Tsutsumi S, Shimazu A, Miyazaki K et al. Retention of multilineage differentiation potential of mesenchymal cells during proliferation in response to FGF. Biochem Biophys Res Commun 2001;288:413-419.
27. Adesida AB, Mulet-Sierra A, Jomha NM. Hypoxia mediated isolation and expansion enhances the chondrogenic capacity of bone marrow mesenchymal stromal cells. Stem Cell Res Ther 2012;3:9.
28. Basciano L, Nemos C, Foliguet B et al. Long term culture of mesenchymal stem cells in hypoxia promotes a genetic program maintaining their undifferentiated and multipotent status. BMC Cell Biol 2011;12:12.
29. Berniakovich I, Giorgio M. Low oxygen tension maintains multipotency, whereas normoxia increases differentiation of mouse bone marrow stromal cells. Int J Mol Sci 2013;14: 2119-2134.
30. Boregowda SV, Krishnappa V, Chambers JW et al. Atmospheric oxygen inhibits growth and differentiation of marrow-derived mouse mesenchymal stem cells via a p53-dependent mechanism: Implications for long-term culture expansion. STEM CELLS 2012;30:975-987.
31. Fehrer C, Brunauer R, Laschober G et al. Reduced oxygen tension attenuates differentiation capacity of human mesenchymal stem cells and prolongs their lifespan. Aging Cell 2007;6:745-757.
32. Grayson WL, Zhao F, Bunnell B et al. Hypoxia enhances proliferation and tissue formation of human mesenchymal stem cells. Biochem Biophys Res Commun 2007;358:948-953.
33. Grayson WL, Zhao F, Izadpanah R et al. Effects of hypoxia on human mesenchymal stem cell expansion and plasticity in 3D constructs. J Cell Physiol 2006;207:331-339.
34. Hung SP, Ho JH, Shih YRV et al. Hypoxia promotes proliferation and osteogenic differentiation potentials of human mesenchymal stem cells. J Orthop Res 2012;30:260-266.
35. Lennon DP, Edmison JM, Caplan AI. Cultivation of rat marrow-derived mesenchymal stem cells in reduced oxygen tension: Effects on in vitro and in vivo osteochondrogenesis. J Cell Physiol 2001;187:345-355.
36. Martin-Rendon E, Hale SJ, Ryan D et al. Transcriptional profiling of human cord blood CD133+ and cultured bone marrow mesenchymal stemcells in response to hypoxia. STEM CELLS 2007;25:1003-1012.
37. Tsai CC, Chen YJ, Yew TL et al. Hypoxia inhibits senescence and maintains mesenchymal stem cell properties through downregulation of E2A-p21 by HIF-TWIST. Blood 2011;117:459-469.
38. Baksh D, Davies JE, Zandstra PW. Adult human bone marrow-derived mesenchymal progenitor cells are capable of adhesionindependent survival and expansion. Exp Hematol 2003;31:723-732.
39. Braccini A, Wendt D, Jaquiery C et al. Three-dimensional perfusion culture of human bone marrow cells and generation of osteoinductive grafts. STEM CELLS 2005;23:1066-1072.
40. Frith JE, Thomson B, Genever PG. Dynamic three-dimensional culture methods enhance mesenchymal stem cell properties and increase therapeutic potential. Tissue Eng Part C Methods 2010;16:735-749.
41. Han S, Zhao Y, Xiao Z et al. The threedimensional collagen scaffold improves the stemness of rat bone marrow mesenchymal stem cells. J Genet Genomics 2012;39:633-641.
42. Scaglione S, Braccini A, Wendt D et al. Engineering of osteoinductive grafts by isolation and expansion of ovine bone marrow stromal cells directly on 3D ceramic scaffolds. Biotechnol Bioeng 2006;93:181-187.
43. Yang Y, Rossi FMV, Putnins EE. Ex vivo expansion of rat bone marrow mesenchymal stromal cells on microcarrier beads in spin culture. Biomaterials 2007;28:3110-3120.
44. Zhao F, Chella R, Ma T. Effects of shear stress on 3-D human mesenchymal stem cell construct development in a perfusion bioreactor system: Experiments and hydrodynamic modeling. Biotechnol Bioeng 2007;96:584-595.
45. Zhao F, Grayson WL, Ma T et al. Effects of hydroxyapatite in 3-D chitosan-gelatin polymer network on human mesenchymal stem cell construct development. Biomaterials 2006;27: 1859-1867.
46. Zhao F, Grayson WL, MaT et al. Perfusion affects the tissue developmental patterns of human mesenchymal stem cells in 3D scaffolds. J Cell Physiol 2009;219:421-429.
47. Hayflick L. The limited in vitro lifetime of human diploid cell strains. Exp Cell Res 1965;37: 614-636.
48. Neuhuber B, Swanger SA, Howard L et al. Effects of plating density and culture time on bone marrow stromal cell characteristics. Exp Hematol 2008;36:1176-1185.
49. Colter DC, Class R, DiGirolamo CM et al. Rapid expansion of recycling stem cells in cultures of plastic-adherent cells from human bone marrow. Proc Natl Acad Sci USA 2000;97:3213-3218.
50. Sekiya I, Larson BL, Smith JR et al. Expansion of human adult stem cells from bone marrow stroma: Conditions that maximize the yields of early progenitors and evaluate their quality. STEM CELLS 2002;20:530-541.
51. Barlow S, Brooke G, Chatterjee K et al. Comparison of human placenta-and bone marrow-derived multipotent mesenchymal stem cells. Stem Cells Dev 2008;17:1095-1107.
52. Mareschi K, Rustichelli D, Calabrese R et al. Multipotent mesenchymal stromal stem cell expansion by plating whole bone marrow at a low cellular density: A more advantageous method for clinical use. Stem Cells Int 2012; 2012:920581.
53. Kulterer B, Friedl G, Jandrositz A et al. Gene expression profiling of human mesenchymal stem cells derived from bone marrow during expansion and osteoblast differentiation. BMC Genomics 2007;8:70.
54. GothardD, DawsonJI, OreffoRO. Assessing the potential of colony morphology for dissecting the CFU-F population from human bone marrow stromal cells. Cell Tissue Res 2013;352:237-247.
55. Schellenberg A, Stiehl T, Horn P et al. Population dynamics of mesenchymal stromal cells during culture expansion. Cytotherapy 2012;14: 401-411.
56. Friedenstein AJ, Latzinik NV, Gorskaya YuF et al. Bone marrow stromal colony formation requires stimulation by haemopoietic cells. Bone Miner 1992;18:199-213.
57. Schellenberg A, Hemeda H, Wagner W. Tracking of replicative senescence in mesenchymal stem cells by colony-forming unit frequency. Methods Mol Biol 2013;976:143-154.
58. Braccini A, Wendt D, Farhadi J et al. The osteogenicity of implanted engineered bone constructs is related to the density of clonogenic bone marrow stromal cells. J Tissue Eng Regen Med 2007;1:60-65.
59. vandenBosC, MoscaJD, Winkles Jetal. Human mesenchymal stem cells respond to fibroblast growth factors. Hum Cell 1997;10:45-50.
60. Globus RK, Plouet J, Gospodarowicz D. Cultured bovine bone cells synthesize basic fibroblast growth factor and store it in their extracellular matrix. Endocrinology 1989;124:1539-1547.
61. Hauschka PV, MavrakosAE, IafratiMDet al. Growth factors in bone matrix. Isolation of multiple types by affinity chromatography on heparin-Sepharose. J Biol Chem 1986;261:12665-12674.
62. McCoy RJ, O'Brien FJ. Influence of shear stress in perfusion bioreactor cultures for the development of three-dimensional bone tissue constructs: A review. Tissue Eng Part B Rev 2010;16:587-601.
63. Mostafa SS, Miller WM, Papoutsakis ET. Oxygen tension influences the differentiation, maturation and apoptosis of human megakaryocytes. Br J Haematol 2000;111:879-889.
64. DiMaggioN, MehrkensA, Papadimitropoulos A et al. Fibroblast growth factor-2 maintains a niche-dependent population of self-renewing highly potent non-adherent mesenchymal progenitors through FGFR2c. STEM CELLS 2012;30: 1455-1464.
65. Di Maggio N, Piccinini E, JaworskiMet al. Toward modeling the bone marrow niche using scaffold-based 3D culture systems. Biomaterials 2011;32:321-329.
66. Keung AJ, Kumar S, Schaffer DV. Presentation counts: Microenvironmental regulation of stem cells by biophysical and material cues. Annu Rev Cell Dev Biol 2010;26:533-556.
67. Tamama K, Kawasaki H, Wells A. Epidermal growth factor (EGF) treatment on multipotential stromal cells (MSCs). Possible enhancement of therapeutic potential of MSC. J Biomed Biotechnol 2010;2010:795385.
68. Kratchmarova I, Blagoev B, Haack-Sorensen M et al. Mechanism of divergent growth factor effects in mesenchymal stem cell differentiation. Science 2005;308:1472-1477.
69. Tamama K, Fan VH, Griffith LG et al. Epidermal growth factor as a candidate for ex vivo expansion of bone marrow-derived mesenchymal stem cells. STEM CELLS 2006;24:686-695.
70. Gharibi B, Hughes FJ. Effects of medium supplements on proliferation, differentiation potential, and in vitro expansion of mesenchymal stem cells. STEM CELLS TRANSLATIONAL MEDICINE 2012;1:771-782.
71. Lennon DP, Haynesworth SE, Young RG et al. A chemically defined medium supports in vitro proliferation and maintains the osteochondral potential of rat marrow-derived mesenchymal stem cells. Exp Cell Res 1995;219:211-222.
72. Bellows CG, Aubin JE, Heersche JN. Initiation and progression of mineralization of bone nodules formed in vitro: The role of alkaline phosphatase and organic phosphate. Bone Miner 1991;14:27-40.
73. Nagai H, Tsukuda R, YamasakiHet al. Systemic injection of FGF-2 stimulates endocortical bone modelling in SAMP6, a murine model of low turnover osteopenia. J Vet Med Sci 1999; 61:869-875.
74. Cooper PD, Burt AM, Wilson JN. Critical effect of oxygen tension on rate of growth of animal cells in continuous suspended culture. Nature 1958;182:1508-1509.
75. Brighton CT, Lorich DG, Kupcha R et al. The pericyte as a possible osteoblast progenitor cell. Clin Orthop Relat Res 1992;275287-299.
76. Tuncay OC, HoD, Barker MK. Oxygen tension regulates osteoblast function. AmJ Orthod Dentofacial Orthop 1994;105:457-463.
77. Bradley TR, Hodgson GS, Rosendaal M. The effect of oxygen tension on haemopoietic and fibroblast cell proliferation in vitro. J Cell Physiol 1978;97(suppl 1):517-522.
78. Kofoed H, Sjøntoft E, Siemssen SO et al. Bone marrow circulation after osteotomy. Blood flow, pO2, pCO2, and pressure studied in dogs. Acta Orthop Scand 1985;56:400-403.
79. Grant JL, Smith B. Bone marrow gas tensions, bone marrow blood flow, and erythropoiesis in man. Ann Intern Med 1963;58:801-809.
80. Frank L, Massaro D. Oxygen toxicity. AmJ Med 1980;69:117-126.
81. Rafiq QA, Brosnan KM, Coopman K et al. Culture of human mesenchymal stem cells on microcarriers in a 5 l stirred-tank bioreactor. Biotechnol Lett 2013;35:1233-1245.
82. Yang S, Leong KF, Du Z et al. The design of scaffolds for use in tissue engineering. Part I. Traditional factors. Tissue Eng 2001;7:679-689.
83. Chen X, Xu H, Wan C et al. Bioreactor expansion of human adult bone marrow-derived mesenchymal stem cells. STEM CELLS 2006;24: 2052-2059.
84. Fassnacht D, Pörtner R. Experimental and theoretical considerations on oxygen supply for animal cell growth in fixed-bed reactors. J Biotechnol 1999;72:169-184.
85. Martin I, Wendt D, Heberer M. The role of bioreactors in tissue engineering. Trends Biotechnol 2004;22:80-86.
86. Rauh J, Milan F, Günther KP et al. Bioreactor systems for bone tissue engineering. Tissue Eng Part B Rev 2011;17:263-280.
87. Peter S, Scutt AM, Wright PC et al. Comparative study of in vitro expansion of bone marrow-derived mesenchymal stem cells. Biotechnol Lett 2013;35:463-469.
88. Holy CE, Shoichet MS, Davies JE. Engineering three-dimensional bone tissue in vitro using biodegradable scaffolds: Investigating initial cell-seeding density and culture period. J Biomed Mater Res 2000;51:376-382.
89. Li Y, Ma T, Kniss DA et al. Effects of filtration seeding on cell density, spatial distribution, and proliferation in nonwoven fibrous matrices. Biotechnol Prog 2001;17:935-944.
90. Morales-Hernandez DG, Genetos DC, Murphy KC et al. Ceramic identity contributes to mechanical properties and osteoblast behavior on macroporous composite scaffolds. J Functional Biomater 2012;3:382-397.
91. Wendt D, Marsano A, Jakob M et al. Oscillating perfusion of cell suspensions through three-dimensional scaffolds enhances cell seeding efficiency and uniformity. Biotechnol Bioeng 2003;84:205-214.
92. Freed LE, Langer R, Martin I et al. Tissue engineering of cartilage in space. Proc Natl Acad Sci USA 1997;94:13885-13890.
93. Sikavitsas VI, Bancroft GN, Holtorf HL et al. Mineralized matrix deposition by marrow stromal osteoblasts in 3D perfusion culture increases with increasing fluid shear forces. Proc Natl Acad Sci USA 2003;100:14683-14688.
94. Alves da Silva ML, Martins A, Costa-Pinto AR et al. Chondrogenic differentiation of human bone marrow mesenchymal stem cells in chitosan-based scaffolds using a flow-perfusion bioreactor. J Tissue Eng Regen Med 2011;5:722-732.
95. Cuthbert R, Boxall SA, Tan HB et al. Singleplatformquality control assay to quantifymultipotential stromal cells inbonemarrowaspiratesprior to bulk manufacture or direct therapeutic use. Cytotherapy 2012;14:431-440.
96. Tsai CC, Chen CL, LiuHCet al. Overexpression of hTERT increases stem-like properties and decreases spontaneous differentiation in human mesenchymal stem cell lines. J Biomed Sci 2010;17:64.
97. van den Dolder J, Bancroft GN, Sikavitsas VI et al. Flow perfusion culture of marrow stromal osteoblasts in titanium fiber mesh. J Biomed Mater Res A 2003;64:235-241.
98. Chen XD, Dusevich V, Feng JQ et al. Extracellular matrix made by bone marrow cells facilitates expansion of marrow-derived mesenchymal progenitor cells and prevents their differentiation into osteoblasts. J Bone Miner Res 2007;22:1943-1956.
99. Decaris ML, Leach JK. Design of experiments approach to engineer cell-secreted matrices for directing osteogenic differentiation. Ann Biomed Eng 2011;39:1174-1185.
100. Gomes ME, Bossano CM, Johnston CM et al. In vitro localization of bone growth factors in constructs of biodegradable scaffolds seeded with marrow stromal cells and cultured in a flow perfusion bioreactor. Tissue Eng 2006;12:177-188.
101. Potier E, Ferreira E, Andriamanalijaona R et al. Hypoxia affects mesenchymal stromal cell osteogenic differentiation and angiogenic factor expression. Bone 2007;40:1078-1087.
102. GalbanCJ, LockeBR. Analysisofcellgrowth kinetics and substrate diffusion in a polymer scaffold. Biotechnol Bioeng 1999;65:121-132.
103. Malda J, Rouwkema J, Martens DE et al. Oxygen gradients in tissue-engineered PEGT/PBT cartilaginous constructs: Measurement and modeling. Biotechnol Bioeng 2004;86:9-18.
104. Damhorst GL, Smith CE, SalmEMet al. A liposome-based ion release impedance sensor for biological detection. Biomed Microdevices 2013;15:895-905.
105. Fite BZ, Decaris M, Sun Y et al. Noninvasive multimodal evaluation of bioengineered cartilage constructs combining time-resolved fluorescence and ultrasound imaging. Tissue Eng Part C Methods 2011;17:495-504.
106. Santoro R, Krause C, Martin I et al. Online monitoring of oxygen as a non-destructive method to quantify cells in engineered 3D tissue constructs. J Tissue Eng Regen Med 2011; 6:696-701.